| Coordination complexes of titanium (IV) for anticancer therapy EY Tshuva, M Miller Metallo-Drugs: Development and Action of Anticancer Agents 18, 219-249, 2018 | 48 | 2018 |
| Insights into molecular mechanism of action of salan titanium (IV) complex with in vitro and in vivo anticancer activity M Miller, O Braitbard, J Hochman, EY Tshuva Journal of Inorganic Biochemistry 163, 250-257, 2016 | 34 | 2016 |
| Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent S Azar, S Udi, A Drori, R Hadar, A Nemirovski, KV Vemuri, M Miller, ... Molecular metabolism 42, 101087, 2020 | 30 | 2020 |
| Cytotoxic titanium (IV) complexes of chiral diaminobis (phenolato) ligands: Better combination of activity and stability by the bipyrrolidine moiety M Miller, EY Tshuva European Journal of Inorganic Chemistry 2014 (9), 1485-1491, 2014 | 21 | 2014 |
| Cytotoxic homoleptic Ti (IV) compounds of ONO-type ligands: synthesis, structures and anti-cancer activity R Manne, M Miller, A Duthie, MFCG da Silva, EY Tshuva, TSB Baul Dalton Transactions 48 (1), 304-314, 2019 | 17 | 2019 |
| ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic M Braun, E Sharon, I Unterman, M Miller, AM Shtern, S Benenson, ... Iscience 23 (8), 2020 | 16 | 2020 |
| Titanium tackles the endoplasmic reticulum: A first genomic study on a titanium anticancer metallodrug M Miller, A Mellul, M Braun, D Sherill-Rofe, E Cohen, Z Shpilt, I Unterman, ... Iscience 23 (7), 2020 | 15 | 2020 |
| Synthesis of pure enantiomers of titanium (IV) complexes with chiral diaminobis (phenolato) ligands and their biological reactivity M Miller, EY Tshuva Scientific Reports 8 (1), 9705, 2018 | 15 | 2018 |
| Racemic vs. enantiopure inert Ti (IV) complex of a single diaminotetrakis (phenolato) ligand in anticancer activity toward human drug-sensitive and-resistant cancer cell lines M Miller, EY Tshuva RSC advances 8 (69), 39731-39734, 2018 | 5 | 2018 |
| Electrochemical triggered dissolution of hydroxyapatite/doxorubicin nanocarriers O Geuli, M Miller, A Leader, L He, N Melamed-Book, EY Tshuva, ... ACS Applied Bio Materials 2 (5), 1956-1966, 2019 | 3 | 2019 |
| Asymmetric inheritance of RNA toxicity in C. elegans expressing CTG repeats M Braun, S Shoshani, J Teixeira, AM Shtern, M Miller, Z Granot, ... Iscience 25 (5), 2022 | 2 | 2022 |
| RNA interference mediates RNA toxicity with parent-of-origin effects in C. elegans expressing CTG repeats M Braun, S Shoshani, J Teixeira, AM Shtern, M Miller, Z Granot, ... bioRxiv, 2021.05. 19.444826, 2021 | 1 | 2021 |
| Titanium-Phenolato Based Anticancer Chemotherapy: Developmental Stages EY Tshuva, M Miller Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, 1-8, 2017 | 1 | 2017 |
| ACE2 Co-Evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic (preprint) M Braun, E Sharon, I Unterman, M Miller, AS Mellul, S Benenson, ... | | 2020 |
| Theoretical Astrophysics 2020-2030 J Kollmeier, L Anderson, A Benson, T Bogdanović, M Boylan-Kolchin, ... Bulletin of the American Astronomical Society 51 (7), 271, 2019 | | 2019 |
| Metallo-drugs: development and action of anticancer agents I Riddell, SJ Lippard, V Brabec, J Kasparkova, V Menon, NP Farrell, ... Walter de Gruyter GmbH & Co KG, 2018 | | 2018 |
| A glimpse into molecular mechanism of phenolato titanium (IV) anticancer complexes M Miller, O Braitbard, Y Smith, J Hochman, EY Tshuva JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY 19, S794-S795, 2014 | | 2014 |
| New Aspects in Mechanism of Action for Titanium Complexes through Stereochemical and Biological Studies M Miller, E Tshuva, O Braitbard, J Hochman JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY 19, S653-S653, 2014 | | 2014 |
| www. expert-reviews. com 541 D Azaña, A Beatty, R Bell, A Benson, A Blackstock, S Boeck, A Brandes, ... | | |
